Results 81 to 90 of about 13,415 (150)

Part V: Clinical Applications of Psoralens, and Related Materials: Clinical Experiences with Methoxsalen in the Treatment of Vitiligo

, 1959
Joseph A. Elliott
openalex   +1 more source

Autologous epidermal grafting with PUVA‐irradiated donor skin for the treatment of vitiligo [PDF]

, 1998
Ai‐Young Lee, Jeong‐Hoon Jang
openalex   +1 more source

Impact of COVID‐19 disease and vaccination on dermatological immune‐mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy

The Journal of Dermatology, Volume 52, Issue 4, Page 624-633, April 2025.
Abstract During the COVID‐19 pandemic, the daily life of many patients with dermatological immune‐mediated inflammatory diseases (DIMIDs), such as atopic dermatitis (AD), psoriasis, and vitiligo, was impacted by social restrictions caused by (fear of) morbidity, mortality associated with COVID‐19, and vaccine hesitancy.
Nicoline F. van Buchem‐Post, Wouter Ouwerkerk, Eileen W. Stalman, Koos P. J. van Dam, Luuk Wieske, Marcel W. Bekkenk, Albert Wolkerstorfer, Phyllis Spuls, Annelie H. Musters, Angela L. Bosma, Dirk‐Jan Hijnen, Filip Eftimov, Rosalie M. Luiten, T2B! immunity against SARS‐CoV‐2 study group, Zoé L. E. van Kempen, Eileen W. Stalman, Maurice Steenhuis, Laura Y. L. Kummer, Koos P. J. van Dam, Anja Ten Brinke, S. Marieke van Ham, Taco Kuijpers, Theo Rispens, Filip Eftimov, Luuk Wieske, Joep Killestein, A. J. Vd Kooi, J. Raaphorst, A. H. Koos Zwinderman, M. Löwenberg, A. G. Volkers, G. R. A. M. D'Haens, R. B. Takkenberg, S. W. Tas, M. L. Hilhorst, Y. Vegting, F. J. Bemelman, N. J. M. Verstegen, L. Fernandez, S. Keijzer, J. B. D. Keijser, O. Cristianawati, A. E. Voskuyl, B. Broens, A. P. Sanchez, S. Nejentsev, E. S. Mirfazeli, G. J. Wolbink, L. Boekel, B. A. Rutgers, K. de Leeuw, B. Horváth, J. J. G. M. Verschuuren, A. M. Ruiter, L. van Ouwerkerk, D. van der Woude, Rcf Allaart, Yko Teng, M. H. Busch, E. Brusse, P. A. van Doorn, Mae Baars, Crg Schreurs, W. L. van der Pol, H. S. Goedee, C. A. C. M. van Els, J. de Wit   +66 more
wiley   +1 more source

Epidemiologic case-control study in patients with vitiligo [PDF]

, 1997
Seung‐Kyung Hann, Hae‐Shin Chung, Yoon‐Kee Park   +2 more
openalex   +1 more source

Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives

Experimental Dermatology, Volume 34, Issue 4, April 2025.
ABSTRACT JAK inhibitors are used to treat various inflammatory skin diseases. However, systemic formulations are associated with an increased risk of major adverse events. Ruxolitinib 1.5% cream is a selective topical JAK1 and JAK2 inhibitor, which has recently been approved by EMA and MHRA for treating non‐segmental vitiligo, while being FDA‐approved ...
Marco Spadafora, Serena Morsia, Vito Giuseppe Di Lernia, Shaniko Kaleci, Giovanni Pellacani, Caterina Longo   +5 more
wiley   +1 more source

LC‐OCT for early diagnosis and characterization of dermatologic adverse events to oncologic drugs and correlation to histopathology

International Journal of Dermatology, Volume 64, Issue 4, Page 719-724, April 2025.
Abstract Background Targeted and immune therapies have recently been associated with the occurrence of multiple cutaneous toxicities, often challenging to differentiate by clinical examination alone without histology. Line‐field confocal optical coherence tomography (LC‐OCT) is a non‐invasive and innovative imaging technique that has been shown to be ...
Pietro Sollena, Marisa Salvi, Marica Marraffa, Luca Pellegrino, Simone Cappilli, Gerardo Palmisano, Maria Mannino, Lucia Di Nardo, Alessandro Di Stefani, Ketty Peris   +9 more
wiley   +1 more source

Local Immune Response in Skin of Generalized Vitiligo Patients [PDF]

, 2000
Renè van den Wijngaard, Anna Wańkowicz-Kalińska, Caroline Le Poole, Bert J Tigges, W. Westerhof, Pranab K. Das   +5 more
openalex   +1 more source

A cross‐sectional study on gender differences in body dysmorphic concerns in patients with skin conditions in relation to sociodemographic, clinical and psychological variables

Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 4, Page 823-832, April 2025.
Abstract Background Dysmorphic concern is an overconcern with an imagined or slight defect in physical appearance that can be a symptom of body dysmorphic disorder (BDD). Appearance‐related concerns are frequently reported by people with dermatological conditions.
F. Sampogna, T. Samela, D. Abeni, C. Schut, J. Kupfer, A. P. Bewley, A. Y. Finlay, U. Gieler, A. R. Thompson, T. Gracia‐Cazaña, F. Balieva, B. R. Ferreira, G. B. Jemec, L. Lien, L. Misery, S. E. Marron, S. Ständer, C. Zeidler, C. Szabó, J. C. Szepietowski, A. Reich, A. Svensson, I. K. Altunay, F. J. Legat, V. Grivcheva‐Panovska, D. V. Romanov, A. N. Lvov, G. Titeca, N. C. Vulink, L. Tomás‐Aragones, S. van Beugen, A. W. M. Evers, F. J. Dalgard, European Society for Dermatology and Psychiatry (ESDaP) Study collaborators   +33 more
wiley   +1 more source

Electron Microscopy of Peripheral Nerve Terminals and Marginal Melanocytes in Vitiligo**From the Departments of Anatomy and Dermatology, St. Mary's Hospital Medical School, (University of London), London, W.2., England.

, 1966
Aodán S. Breathnach, Simon Bor, Lucilec M.-A. Wyllie   +2 more
openalex   +1 more source

Elimination of CD4+ T Cells Enhances Anti-Tumor Effect of Locally Secreted Interleukin-12 on B16 Mouse Melanoma and Induces Vitiligo-Like Coat Color Alteration [PDF]

, 2000
Hiroshi Nagai, Tatsuya Horikawa, Masahiro Oka, Masamitsu Ichihashi, Isao Hara, Sadao Kamidono   +5 more
openalex   +1 more source